How far away are intellectual property rights?
Release time:
2020-08-14
How far is intellectual property from us?
In 2016 , a piece of news called "Huawei's counterattack to Apple to collect royalties" once became a hot topic in the community. Although this news has been circulating in the small circle of the mobile phone industry for a long time, it is absolutely new to the common people-Apple, the top company in the mobile phone industry, has to pay money to Huawei?
According to the licensing registration information published by the State Intellectual Property Office, Huawei licensed 769 patents to Apple in 2015 , and Apple licensed 98 patents to Huawei. Judging from the widely different figures, it is not too much to call it "counter attack. Some people may think that this is because of technology transfer between peers, but in fact, even if Huawei does not have a mobile phone business, Apple will still pay a lot of fees to it, because as a global mainstream telecom equipment supplier, Huawei holds many necessary patents for the 4G standard. In the same way, the reason why Huawei has been able to develop rapidly in the mobile phone business is not only its own patent advantages, but also an important reason for paying fees to patent giants such as Apple and Ericsson to obtain authorization.
From this example, it is not difficult to see that intellectual property, an intangible asset, can be transformed into tangible economic benefits as long as it has certain advantages and is used properly.
Some people may say that network communication is a knowledge-intensive industry with high technology content. It is normal to have many inventions and patents. The main business of peak is traditional manufacturing. When it comes to pharmaceutical industry and research and development of new products, if it is a cement industry with very mature technology, it is too far away from the words "scientific research", "invention" and "patent. However, in the intellectual property knowledge training organized by the company on 11 22 , some examples cited by the teacher subverted this concept-many domestic cement enterprises have more than 100 independent invention patents, which are no less than those owned by Jianfeng Pharmaceutical. This simple comparison of figures is enough to show that our previous understanding of the concept of "intellectual property" is still too superficial, and there are many deficiencies in the work on intellectual property.
According to the official interpretation, intellectual property is the ownership of the results of intellectual labor, which is the exclusive right granted to qualified authors, inventors or owners of the results for a certain period of time in accordance with the laws of various countries. Intellectual property rights are mainly divided into two categories: copyright and industrial property rights. Among them, industrial property rights that are closely related to business operations can be divided into trademark rights and patent rights. As a company with well-known trademarks in China and well-known trademarks in Zhejiang Province, we are relatively familiar with trademark rights in our daily work, and we have also done a lot of work in combating trademark infringement and maintaining market stability; but for patent rights, many people still think That is Edison's "business scope". In fact, this idea is not only wrong, but also a great underestimate of our own ability.
According to China's "Patent Law", there are three types of inventions, inventions, utility models and designs. Let's not talk about the "invention" that looks very "tall". In terms of "utility model", it refers to "a new technical scheme suitable for practicality proposed for the shape, structure or combination of the product". That is to say, whether it is Jianfeng Pharmaceutical or cement, as one of the daily key tasks, technological transformation, process innovation, formula adjustment and process optimization, they are all covered by "utility models"; small inventions and small creations that we have made in recent years to promote "three reductions and three improvements" may become patents; even, every rationalization proposal put forward by employees, Every small innovation carried out may make them the owners of patent rights. As for the design patent, it gives us more room to think.
In today's era of knowledge explosion and rapid development of science and technology, new technologies and new achievements emerge one after another, and the speed of transformation, update and elimination of achievements is greatly accelerated. It is impossible for any enterprise or industry to develop behind closed doors. It is bound to overlap with other industries and other enterprises, especially the application of new technologies and new achievements. In this context, it is almost impossible to invent and create in the "nothing" style like Edison's time. Perhaps because of this, although we are thinking and implementing innovations and improvements every day, and have achieved results and produced practical results in practical applications, most of the intellectual property rights and their derivative values of these results lack sufficient attention.
The current market competition is multifaceted. Although intellectual property rights are intangible "soft power", they often produce "hard effects" that establish competitive advantages ". In recent years, the company has paid more and more attention to intellectual property work such as brand management and patent declaration, but compared with outstanding companies in the same industry, there is indeed a big gap. The implementation of intellectual property strategy focuses on cultivating the awareness and means of supporting enterprises in the protection and utilization of intellectual property rights, and guiding enterprises to enhance their ability to create, utilize, manage and operate intellectual property rights in the market competition. Therefore, while constantly innovating and catching up with others, we should also carefully sort out what we have done and see what we have overlooked over the years that could have been more shining. (Hong Tao)
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page